Xiao-Ming Lin

1.5k total citations
36 papers, 1.1k citations indexed

About

Xiao-Ming Lin is a scholar working on Biochemistry, Molecular Biology and Ophthalmology. According to data from OpenAlex, Xiao-Ming Lin has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Biochemistry, 9 papers in Molecular Biology and 8 papers in Ophthalmology. Recurrent topics in Xiao-Ming Lin's work include Antioxidant Activity and Oxidative Stress (16 papers), Retinal Diseases and Treatments (8 papers) and Retinoids in leukemia and cellular processes (7 papers). Xiao-Ming Lin is often cited by papers focused on Antioxidant Activity and Oxidative Stress (16 papers), Retinal Diseases and Treatments (8 papers) and Retinoids in leukemia and cellular processes (7 papers). Xiao-Ming Lin collaborates with scholars based in China, United States and Canada. Xiao-Ming Lin's co-authors include Le Ma, Zhiyong Zou, Xianrong Xu, Yangmu Huang, Hongliang Dou, Xin Xiao, Yiqun Wu, Xun Wang, Xinrong Lu and Yubei Huang and has published in prestigious journals such as Scientific Reports, Free Radical Biology and Medicine and Ophthalmology.

In The Last Decade

Xiao-Ming Lin

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiao-Ming Lin China 16 581 324 290 145 117 36 1.1k
Judy D. Ribaya‐Mercado United States 21 768 1.3× 506 1.6× 28 0.1× 16 0.1× 455 3.9× 32 1.5k
Vidosava Djordjević Serbia 14 54 0.1× 168 0.5× 40 0.1× 64 0.4× 57 0.5× 36 723
Enhui Li China 12 136 0.2× 351 1.1× 33 0.1× 19 0.1× 62 0.5× 36 717
Xiaoli Ma China 18 42 0.1× 277 0.9× 48 0.2× 54 0.4× 56 0.5× 49 856
Tomasz Sozański Poland 19 285 0.5× 283 0.9× 15 0.1× 14 0.1× 65 0.6× 66 1.0k
Farida M. Al-Awadi Kuwait 15 65 0.1× 225 0.7× 39 0.1× 14 0.1× 144 1.2× 32 883
Saliha Rizvi India 10 133 0.2× 256 0.8× 15 0.1× 13 0.1× 126 1.1× 27 842
H. Bachmann Switzerland 6 251 0.4× 294 0.9× 15 0.1× 10 0.1× 138 1.2× 12 894
Hui Zou China 16 111 0.2× 259 0.8× 20 0.1× 9 0.1× 166 1.4× 55 842
Xiaojing Liu China 16 55 0.1× 149 0.5× 18 0.1× 40 0.3× 59 0.5× 40 538

Countries citing papers authored by Xiao-Ming Lin

Since Specialization
Citations

This map shows the geographic impact of Xiao-Ming Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao-Ming Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao-Ming Lin more than expected).

Fields of papers citing papers by Xiao-Ming Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao-Ming Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao-Ming Lin. The network helps show where Xiao-Ming Lin may publish in the future.

Co-authorship network of co-authors of Xiao-Ming Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao-Ming Lin. A scholar is included among the top collaborators of Xiao-Ming Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao-Ming Lin. Xiao-Ming Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jincheng, Ting Huang, Xiao-Ming Lin, et al.. (2025). Complement C5aR blockade attenuates LPS-induced acute kidney injury by regulating ferroptosis via nuclear factor-erythroid 2-related factor 2 signaling in mice. Free Radical Biology and Medicine. 239. 104–115. 2 indexed citations
2.
Bertucci, Vince, Joel Schlessinger, John Joseph, et al.. (2024). Efficacy and Safety of a Novel Formulation Liquid Botulinum Toxin, RelabotulinumtoxinA, When used for Combination Treatment of Glabellar and Lateral Canthal Lines. Toxicon. 237. 107369–107369. 1 indexed citations
3.
Zhang, Jincheng, Xiao-Ming Lin, Ting Huang, et al.. (2024). Inhibition of colon C5a/C5a receptor signalling pathway confers protection against LPS-induced acute kidney injury via gut microbiota-kidney axis. European Journal of Pharmacology. 969. 176425–176425. 5 indexed citations
4.
Li, Qingsheng, et al.. (2017). Effect of fluoride treatment on gene expression in tea plant (Camellia sinensis). Scientific Reports. 7(1). 9847–9847. 36 indexed citations
5.
6.
Huang, Yangmu, Hongliang Dou, Feifei Huang, et al.. (2014). Changes following supplementation with lutein and zeaxanthin in retinal function in eyes with early age-related macular degeneration: a randomised, double-blind, placebo-controlled trial. British Journal of Ophthalmology. 99(3). 371–375. 40 indexed citations
7.
Huang, Yangmu, Le Ma, Zhiyong Zou, et al.. (2013). Serum and macular responses to multiple xanthophyll supplements in patients with early age-related macular degeneration. Nutrition. 29(2). 387–392. 23 indexed citations
8.
Lin, Xiao-Ming. (2012). Relationship Between Smoking and Alcohol Intake and Blood Pressure in Urban Residents in Hulunbeier. 1 indexed citations
9.
Xu, Xianrong, Zhiyong Zou, Xin Xiao, et al.. (2012). Effects of Lutein Supplement on Serum Inflammatory Cytokines, ApoE and Lipid Profiles in Early Atherosclerosis Population. Journal of Atherosclerosis and Thrombosis. 20(2). 170–177. 54 indexed citations
10.
Xu, Xianrong, Zhiyong Zou, Yangmu Huang, et al.. (2012). Serum carotenoids in relation to risk factors for development of atherosclerosis. Clinical Biochemistry. 45(16-17). 1357–1361. 34 indexed citations
11.
Ma, Le, Hongliang Dou, Yangmu Huang, et al.. (2012). Improvement of Retinal Function in Early Age-Related Macular Degeneration After Lutein and Zeaxanthin Supplementation: A Randomized, Double-Masked, Placebo-Controlled Trial. American Journal of Ophthalmology. 154(4). 625–634.e1. 64 indexed citations
12.
Zou, Zhiyong, Xianrong Xu, Yangmu Huang, et al.. (2011). High serum level of lutein may be protective against early atherosclerosis: The Beijing atherosclerosis study. Atherosclerosis. 219(2). 789–793. 47 indexed citations
13.
Ma, Le, Hongliang Dou, Yiqun Wu, et al.. (2011). Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis. British Journal Of Nutrition. 107(3). 350–359. 166 indexed citations
14.
Lin, Xiao-Ming. (2010). Protection of Lutein on Early Atherosclerosis and Its Mechanism. 1 indexed citations
15.
Zou, Zhiyong, Xiao-Ming Lin, Xianrong Xu, et al.. (2009). Evaluation of milk basic protein supplementation on bone density and bone metabolism in Chinese young women. European Journal of Nutrition. 48(5). 301–306. 20 indexed citations
16.
Ma, Le & Xiao-Ming Lin. (2009). Effects of lutein and zeaxanthin on aspects of eye health. Journal of the Science of Food and Agriculture. 90(1). 2–12. 170 indexed citations
17.
Lin, Xiao-Ming. (2008). THE RESPONSES OF VISUAL FUNCTION TO LUTEIN SUPPLEMENTS IN PEOPLE WITH LONG-TERM DISPLAY LIGHT EXPOSURE. Acta Nutrimenta Sinica. 2 indexed citations
18.
Lin, Xiao-Ming, et al.. (2008). Evaluation of serum transferrin receptor for iron deficiency in women of child-bearing age. British Journal Of Nutrition. 100(5). 1104–1108. 5 indexed citations
19.
Lin, Xiao-Ming, et al.. (2007). The responses of serum transferrin receptors to iron supplements in subjects with iron-deficiency erythropoiesis and iron-deficiency anaemia. British Journal Of Nutrition. 99(2). 416–420. 5 indexed citations
20.
Lin, Xiao-Ming, et al.. (2003). [Iron status and effect of early iron supplementation on sub-clinical iron deficiency in rural school-age children from mountainous areas of Beijing].. PubMed. 37(2). 115–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Judy D. Ribaya‐Mercado Breakdown of academic impact, for papers by Vidosava Djordjević Breakdown of academic impact, for papers by Enhui Li Breakdown of academic impact, for papers by Xiaoli Ma Breakdown of academic impact, for papers by Tomasz Sozański Breakdown of academic impact, for papers by Farida M. Al-Awadi Breakdown of academic impact, for papers by Saliha Rizvi Breakdown of academic impact, for papers by H. Bachmann Breakdown of academic impact, for papers by Hui Zou Breakdown of academic impact, for papers by Xiaojing Liu
Rankless by CCL
2026